Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 7/20 | 0.66 |
| ▸ | P2RX1 | P51575 | 4/20 | 0.66 |
| ▸ | P2RX2 | Q9UBL9 | 3/20 | 0.66 |
| ▸ | P2RX4 | Q99571 | 6/20 | 0.64 |
| ▸ | P2RY1 | P47900 | 5/20 | 0.64 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.64 |
| ▸ | SRC | P12931 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.61 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.60 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.60 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.60 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.60 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12932293 | 1.00 | P2RX3 (0.66) | P2RX3P2RX1P2RX2P2RX4P2RY1 | |
| SCHEMBL15698480 | 1.00 | P2RX3 (0.66) | P2RX3P2RX1P2RX2P2RX4P2RY1 | |
| SCHEMBL21417366 | 0.91 | P2RY1 (0.66) | P2RY1P2RY2SRCSMN1; SMN2RNASEL | |
| SCHEMBL20324919 | 0.91 | P2RY1 (0.66) | P2RY1P2RY2SRCSMN1; SMN2RNASEL | |
| SCHEMBL20326922 | 0.91 | P2RY1 (0.66) | P2RY1P2RY2SRCSMN1; SMN2RNASEL | |
| SCHEMBL20224844 | 0.91 | P2RY1 (0.66) | P2RY1P2RY2SRCSMN1; SMN2RNASEL | |
| SCHEMBL22571185 | 0.90 | P2RY1 (0.57) | P2RX3P2RX1P2RX2P2RX4P2RY1 | |
| SCHEMBL23982340 | 0.90 | P2RX1 (0.70) | P2RX3P2RX1P2RX2P2RX4P2RY1 | |
| SCHEMBL19493160 | 0.90 | P2RX1 (0.70) | P2RX3P2RX1P2RX2P2RX4P2RY1 | |
| SCHEMBL3163036 | 0.90 | P2RX1 (0.70) | P2RX3P2RX1P2RX2P2RX4P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600957-B2 | Synthesis of transcripts using VSW-3 RNA polymerase | RNASYN BIOTECH. CO., LTD. (CN) | 2026-04-14 | — | — | US | claimed |
| US-20240309447-A1 | METHODS AND KITS FOR PREPARING A SAMPLE COMPRISING ONE OR MORE RNA MOLECULES FOR SEQUENCING | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-09-19 | — | — | US | claimed |
| US-20220220459-A1 | SYNTHESIS OF TRANSCRIPTS USING VSW-3 RNA POLYMERASE | RNASYN BIOTECH. CO., LTD. (CN) | 2022-07-14 | — | — | US | claimed |
| US-12600957-B2 | Synthesis of transcripts using VSW-3 RNA polymerase | RNASYN BIOTECH. CO., LTD. (CN) | 2026-04-14 | — | — | US | disclosed |
| US-20250223620-A1 | NOVEL PROCESSES FOR THE PRODUCTION OF POLYNUCLEOTIDES INCLUDING OLIGONUCLEOTIDES | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2025-07-10 | — | — | US | disclosed |
| US-20240309447-A1 | METHODS AND KITS FOR PREPARING A SAMPLE COMPRISING ONE OR MORE RNA MOLECULES FOR SEQUENCING | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-09-19 | — | — | US | disclosed |
| CN-116732020-A | Methods for improving the efficiency and/or stability of intracellular translation of RNA molecules | 中国科学院分子细胞科学卓越创新中心 | 2023-09-12 | — | — | CN | disclosed |
| WO-2023165530-A1 | METHODS OF INCREASING INTRACELLULAR TRANSLATIONAL EFFICIENCY AND/OR STABILITY OF RNA MOLECULES | 中国科学院分子细胞科学卓越创新中心 | 2023-09-07 | — | — | WO | disclosed |
| US-20220220459-A1 | SYNTHESIS OF TRANSCRIPTS USING VSW-3 RNA POLYMERASE | RNASYN BIOTECH. CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600957-B2 | Synthesis of transcripts using VSW-3 RNA polymerase | POLR2H, POLL, POLR2E | P2RX3 822/4885P2RX1 1618/4885P2RX2 1078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.